LEADER 04386nam 22006015 450 001 9910483040803321 005 20260119101530.0 010 $a981-336-404-1 024 7 $a10.1007/978-981-33-6404-2 035 $a(CKB)4100000011781556 035 $a(MiAaPQ)EBC6509893 035 $a(Au-PeEL)EBL6509893 035 $a(OCoLC)1243534622 035 $a(PPN)253857554 035 $a(DE-He213)978-981-33-6404-2 035 $a(EXLCZ)994100000011781556 100 $a20210226d2021 u| 0 101 0 $aeng 135 $aurcnu|||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aMoyamoya Disease: Current Knowledge and Future Perspectives /$fedited by Satoshi Kuroda 205 $a1st ed. 2021. 210 1$aSingapore :$cSpringer Nature Singapore :$cImprint: Springer,$d2021. 215 $a1 online resource (xv, 341 pages) $cillustrations 225 1 $aMedicine Series 311 08$a981-336-403-3 327 $aPart I Concept of Moyamoya Disease -- 1 History of Disease Entity & Diagnosis Criteria -- 2 Moyamoya Syndrome -- 3 Unilateral Moyamoya Disease: A Distinct Entity? -- Part II Genetic Aspect of Moyamoya Disease -- 4 RNF213 as Susceptibility Gene -- 5 RNF213 and clinical feature -- 6 RNF213 Variant as a Biomarker of Cerebrovascular Disease -- Part III Pathophysiology of Moyamoya Disease -- 7 TIA & Headache in Pediatric Moyamoya Disease -- 8 Ischemic stroke -- 9 Hemorrhagic Stroke and the Japan Adult Moyamoya Trial -- 10 Cognitive Function in Pediatric Moyamoya Disease -- 11 Cognitive Dysfunction in Adults -- 12 Asymptomatic Moyamoya Disease -- Part IV Update on Neuroradiology in Moyamoya Disease -- 13 Periventricular Anastomosis -- 14 Arterial Shrinkage -- 15 Disease progression -- 16 Postoperative hyperperfusion -- 17 Postoperative FLAIR Imaging Changes -- Part V Real World of Surgical Revascularization for Moyamoya Disease -- 18 Overview of Surgical Revascularization and Long-term Outcome in Japan -- 19 Perioperative complications -- 20 Long-term Outcome in Europe -- 21 Long Term Outcomes in USA -- 22 Long-term Outcome in China -- 23 Long-term outcome of revascularization surgery for moyamoya disease in Korea -- 24 Indirect bypass surgery for moyamoya disease -- 25 Direct/combined bypass surgery -- 26 Special Considerations?Infants -- 27 Special Considerations ? Elderly. 330 $aThis book brings together the latest knowledge on moyamoya disease, covering diagnostic criteria, status as a disease entity, genetic aspects, pathophysiology, novel neuroradiological findings, and surgical therapy. Information is also provided on recent basic and clinical research with the aim of identifying future perspectives on the disease. Since moyamoya disease was first reported in an English language article more than 50 years ago, our understanding of it has advanced considerably. Genetic and radiological analysis has delivered novel insights, and the latest multicenter studies are changing routine diagnosis and surgical therapy. The gene encoding the ring finger protein 213 (RNF213) has been identified as a susceptibility gene for moyamoya disease. Indications and procedures for surgical revascularization have been revised, with resultant improvements in outcomes, and studies performed over the past decade have provided new knowledge on the neuroradiological findings before and after surgery. In describing these advances, this book will be an invaluable asset for all general physicians, pediatricians, neurologists, radiologists, and neurosurgeons who care for patients with moyamoya disease across the world. 410 0$aMedicine Series 606 $aNervous system$xSurgery 606 $aNervous system$xRadiography 606 $aNeurosurgery 606 $aNeuroradiology 606 $aMalalties cerebrovasculars$2thub 606 $aNeurocirurgia$2thub 608 $aLlibres electrònics$2thub 615 0$aNervous system$xSurgery. 615 0$aNervous system$xRadiography. 615 14$aNeurosurgery. 615 24$aNeuroradiology. 615 7$aMalalties cerebrovasculars 615 7$aNeurocirurgia 676 $a617.48 702 $aKuroda$b Satoshi 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910483040803321 996 $aMoyamoya disease$91898181 997 $aUNINA